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Syntheses of small cluster oligosaccharide mimetics 
 
Andreas H. Franz,* Paul H. Gross, and Vyacheslav V. Samoshin 
 
Department of Chemistry, University of the Pacific, Stockton, CA 95211, USA 
E-mail: afranz@pacific.edu, vsamoshin@pacific.edu 
 




We designed multiple Small Cluster Oligosaccharide Mimetics (SCOMs) - potential glycosidase 
inhibitors - to be metabolically stable and small enough to enter cells or bacteria. Therefore, 
minimal scaffolds (urea, amide, ammonia) or simply non-glycosidic linkages of carbohydrate 
structures were central to our synthetic strategy, including: (a) coupling of several natural 
carbohydrate precursors; (b) total syntheses of aminomethyl tetrahydropyrans and their chiral 
amides with quinic acid; (c) glycopyranosyl cyanide reduction to prepare crowded clusters on a 
urea scaffold; (d) total syntheses via cycloadditions leading to amide-linked C-glycosides; (e) 
reduction of nitromethyl C-glycosides; and (f) a synthesis of hydroxylated 1,2-
cyclohexanedicarboxylic acids. 
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1. Introduction 
 
After the early years of carbohydrate chemistry around 1900 and Emil Fischer’s structure proof 
of the carbohydrates, this area of chemistry received only little attention. However, carbohydrate 
chemistry witnessed a renaissance during the 1960’s with the advent of the aminoglycoside 
antibiotics.1-3 Synthetic efforts since then have resulted in numerous structural modifications for 
carbohydrates. Exchange of aglycons on the anomeric carbon, exchange of the glycosidic atom 
(N-, C-, S-glycosides), exchange of ring substitutents, exchange of the endocyclic heteroatom 
(carba-, aza-, thia-derivatives), and concise streochemical transformations. Oligosaccharides are 
now recognized to have functions influencing the entire spectrum of cell activities. Glycolipids 
and glycoproteins on the cell surface are now known to determine cell-cell interactions with 
invading bacteria, viruses, and cancer cells.4-7 Carbohydrates play central roles in 
posttranslational modifications of proteins,8-10 cell-cell communication,11 and immune response 
to pathogens.10,12-14 Aberrations in glycosylation have been linked to severe pathological 
symptoms. Monosaccharide units combine to oligosaccharides in an almost infinite number of 
permutations, determined by the stereochemical identity of the linked monosaccharides (e.g. 
glucose, galactose, mannose), their glycosidic linkage position (e.g. 1→4, 1→6), their 
anomericity (α or β), and the overall degree of branching. This complexity, further increased by 
additional modifications such as sulfation or sialation, was suggested recently to serve the 
evolutionary purpose of “herd immunity”.15,16 It has become clear over the past three decades 
that glycosylation is critically important to many of the signaling pathways that turn a normal 
cell into a cancer cell. Compounds that inhibit specific glycosylation reactions may potentially 
block the pathways in carcinogenesis. Carbohydrates have been recognized as novel cancer 
prevention agents.17 
 However, a distinct disadvantage of naturally occurring carbohydrates, e. g.  
O-glycosidically-linked oligosaccharides, is their metabolic instability in biological systems. 
Therefore, much effort has been spent in the past two decades on the development of feasible 
pathways towards carbohydrate mimetics, including C-glycosidic sugars,18-21 which may 
compete with their O-glycosidic counterparts in cell surface adhesion, inhibit carbohydrate-
processing enzymes, and interfere in the biosynthesis of specific cell surface carbohydrates.21-23 
Therefore, carbohydrate mimetics are potential therapeutic agents against HIV and other 
infections, against cancer, diabetes and other metabolic diseases.18-23 
 Oligosaccharide “clusters” exhibit greatly increased binding constants compared to 
monosaccharides (cluster effect).24-29 Potential targets for medical applications of these clusters 
have been identified.30 However, most synthesized glycosidic cluster compounds are too large to 
permeate cell walls or membranes, and only target cell surface receptors.24-29 Therefore, we 
devoted our work to the synthesis of a variety of Small Cluster Oligosaccharide Mimetics 
(SCOMs)31,32 with enhanced metabolic stability, which presumably may enter the cytosol and 
internal cell substructures to address internal receptors. 
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2. Acylation with Quinic Lactone 
 
Quinic acid (1, Figure 1)33 and its derivative shikimic acid (2, Figure 1)34-36 (from Illicium 
japonica and floridanum) are key intermediates during the biochemical synthesis of essential 
aromatic amino acids, such as L-tryptophan, L-phenylalanine, and L-tyrosine in plants, bacteria, 
and fungi. Quinic acid and shikimic acid are also required as building blocks for the assimilation 
of folic acid, alkaloids, and vitamins in those organisms.37,38 The quinic acid/shikimic acid 
pathway does not exist in mammals, which has led to extensive research activities geared 
towards the development of suitable antibiotic therapeutics. Especially the conversion of 3-
dehydroquinic acid (DHQ) to 3-dehydroshikimic acid (DHS) has been recognized as an effective 
target for inhibition in plants.39,40 Several commercial herbicides selectively inhibit the DHQ-
DHS conversion and prevent growth of weeds. However, disruption of the DHQ-DHS pathway 
by shikimic acid derivatives (3, Figure 1) has also recently been shown to cause therapeutic 
inhibition of Mycobacterium tuberculosis.41  
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Figure 1. Chemical structures of quinic acid (1), shikimic acid (2). Compounds 3, 4 (TamifluTM, 
Roche), and 5 (RelenzaTM, Glaxo-Smith) show anti-influenza activity. 
 
 Derivatives of shikimic acid have been used to inhibit other biochemical pathways for 
example the infectious pathway of the influenza virus (common flu).42-44 Potent anti-influenza 
A+B effect has been observed for derivatives of shikimic acid inhibiting viral neuraminidase. 
The widely-prescribed anti-flu medication TamifluTM (Roche, 4, Figure 1) is not only effective in 
treating common flu strains, but it has also been used successfully in the treatment of the bird 
(avian) flu in laboratory animals. Contrary to animal experiments, Tamiflu’sTM effectiveness in 
humans infected with the H5N1 flu strain is still controversial because only a few studies with 
limited statistical value have been conducted, and the understanding of the drug’s action against 
the virus is only rudimentary. TamifluTM acts as influenza virus neuraminidase inhibitor with the 
possibility of alteration of virus particle aggregation and release. The less well-known RelenzaTM 
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(Zanamivir, GlaxoSmithKline, 5, Figure 1)42 is also an effective inhibitor of common flu strains 
by the same mechanism. The problem of a sufficient supply of these two drugs in case of an 
influenza pandemic and the necessity for a continuous search for new structural analogs has been 
discussed in the literature.45,46  
 For the construction of SCOMs from quinic acid, we used 2-amino-2-deoxy sugars as 
nucleophiles and quinic lactone as an electrophile (Scheme 1).47-49 Starting with 2-acetamido-2-
deoxy-D-glucopyranose (6), we prepared the corresponding benzyl glucoside (7) through acid-
catalyzed acetal formation. Under these conditions, compound 7 was obtained as a mixture of 
anomers, which was difficult to separate or crystallize. However, the α- and β-anomer can be 
obtained clean after per-O-acetylation, recrystallization, and MeO
-
/MeOH deprotection at room 
temperature.50 Compound 7 was then converted to the 4,6-O-benzylidene derivative 8 with 
benzaldehyde and anhydrous ZnCl2 followed by removal of the N-acetyl group in ethanolic KOH 
at reflux to yield 2-amino-4,6-O-benzylidene-2-deoxy-α/β-D-glucopyranose (9). In parallel,  
D-(-)-quininc acid was converted to the 4,5-O-isopropylidenated lactone (11),51 which served as 
an electrophile in the subsequent acylation of the separated α- and β-anomers 9a/b into the 
potential disaccharide mimic precursors 12a/b, respectively. 
 We also prepared compounds 21 and 22 as regio- and diastereochemical analogs of 12, 
respectively. The two corresponding aminoglycosides were synthesized from D-glucose (14).52 
Benzylation followed by 4,6-O-benzylidenation gave compound 16 whose 2- and 3-hydroxyl 
groups were subsequently mesylated to afford compound 17. Upon treatment of 17 with 
methoxide, we were able to obtain benzyl-2,3-anhydro-4,6-O-benzylidene-α-D-allopyranoside 
(18). The epoxide was surprisingly stable but could be opened with NH3 under pressure and 
elevated temperature. The major product (20) with D-altro-configuration was obtained through 
diaxial opening (Fuerst-Plattner rule) whereas the regioisomer (19) with D-gluco-configuration 
was only isolated in small quantities from the same reaction. When these products were 
combined with quinic lactone 11, SCOMs 21 and 22 were obtained, respectively.  
 Interestingly, the quinic amide ring in all quinamides described above had a predominant 
twist-boat conformation as determined by NMR in CDCl3 (Scheme 1).47,48 This was confirmed 
by small gauche 3J-values and NOEs between H3/H2a/H2b and between H5/H6a/H6b, as well as 
a significant 4J  between H4 and H2b (W-coupling). We observed the same conformation for the 
unsubstituted quinamide 13 that was obtained from 11 in a saturated methanolic solution of NH3 
at room temperature. This benzylamide derivative had been described by us earlier; however, 
without detailed conformational analysis (Scheme 1).49 The twist-boat conformation is pretty 
common for the pyranoses/tetrahydropyranes fused to five-membered acetal ring(s) (e.g. see 
Section 4.1), but is very rare for cyclohexane derivatives. 
 Quinic lactone 11 was also used for acylation of synthesized aminomethyl-C-
dideoxyglycopyranosides (Section 7). 
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Scheme 1.  Quinamide SCOMs synthesized through nucleophilic opening of quinic lactone.47-49 
The molecular models represent 0K structures obtained from molecular dynamics simulation 
(AM1) with temperature annealing. 
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3. Glycal Dimerization 
 
Glycals (1,2-eno-pyranoses or -furanoses) are versatile chiral building blocks in the synthesis of 
natural products and biologically relevant oligosaccharides,53 because of the ease of their 
chemical transformation.54-57 Synthetic oligosaccharides derived from glycals have been tested as 
antigens in anti-cancer vaccination.53,58 
 Glycals are classically synthesized by reduction (1,2-deacetoxybromination) of  
per-O-acetylated glycosyl bromides in glacial AcOH/NaOAc buffer with Zn.59,60 However, these 
literature procedures have serious problems,59-61 among which solvolysis of the unstable 
intermediate glycosyl bromides is the major one. 
 We have developed a synthesis of acetylated glycosyl bromides and subsequently glycals 
from per-acetylated sugars under non-solvolytic conditions.62-64 In the first step a per-O-
acetylated sugar was treated with TiBr4 in CH2Cl2 in presence of a catalytic amount of glacial 
acetic acid. The resulting glycosyl bromide was in situ reduced with Zn/Cu couple. Per-O-
acetylated D-glucose, D-galactose, D-glucuronic acid methyl ester, L-fucose, D-maltose,  
D-lactose, and D-gentiobiose gave corresponding glycals 23-30 (Figure 2) in > 90% purity prior 



























































































Figure 2. Glycals synthesized under aprotic conditions.62-64  
 
 Dimerization of per-O-acetylated D-glucal was described first by Ferrier and Prasad.65 In a 
similar fashion we synthesized products with directly C-linked cycles (Scheme 2)62-64,66-69 by an 
improved dimerization method with BF3/Ac2O catalyst,67 and also obtained tetrasaccharidic 
glycomimetics from disaccharidic glycals (Scheme 3).62-64,66-69  
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Scheme 3. Dimerization of per-O-acetyl-cellobial 27 and per-O-acetyl-lactal 28.62-64,66-69 
 
 Such compounds may potentially show altered and/or enhanced bioactivity due to a well-
documented cluster effect.24-29 The non-physiological nature of the new C-C-linkages in our 
compounds may transfer metabolic stability also to O-glycosidic bonds still present in their 
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structures. Dimerizations of disaccharidic glycals to tetramers required careful optimization of 
conditions to minimize cleavage of the disaccharidic bonds by the BF3-catalyst. 
 The structural assignment of glycal dimers was based upon NMR data. The original 
assignment for tri-O-acetyl-D-glucal dimer 3165 was confirmed by our data,64,66 and finally 




Figure 3.  Molecular structure of compound 31.66 
 
 The structural analysis of 31 revealed a high degree of rigidity in the molecule. Comparative 
analysis of the NMR and X-ray data62,64,66 shows that there is virtually no difference between the 
solution and crystal conformations of both rings in compound 31. The average position of the 
two ring planes in 31 may be considered nearly perpendicular. The conformational equilibrium 
for both rings appears to be strongly biased. An absence of a solvent dependence for spin-spin 
coupling constants also supports these conclusions. 
 The results of this work combined with literature data allowed us to suggest a set of 
“standard” coupling constants for use in structural analysis of 2,3-dideoxy-2-enopyranose 
systems with α-erythro configuration in the unusual 5HO-conformation and more common OH5-















3J1,2 = 0-2 Hz
4J1,3 = 0-2.5 Hz
3J3,4 = 4.8-5.7 Hz
4J2,4 = 0-1.5 Hz
3J4,5 = < 1 Hz
3J1,2 = 2.2 Hz
4J1,3 = < 0.3 Hz
3J3,4 = 2.2 Hz
4J2,4 = n. det.
3J4,5 = 6.3-9.0 Hz5HO
OH5  
 
Figure 4. Refined “standard” coupling constants for 5HO- and OH5-conformations of 2,3-
dideoxy-2-enopyranose system.62,64,66 
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4. Synthesis and Reduction of Glycosyl Cyanides 
4.1. Glycosyl cyanides from glycosyl acetates 
 
Another way to render carbohydrate-derived structures metabolically more stable is offered by 
introducing a C-glycosidic cyanide functionality. In 1961 Helferich and Bettin obtained per-O-
acetyl-β-D-galactopyranosyl cyanide in good yield from per-O-acetyl-α-D-galactopyranosyl 
bromide and mercuric cyanide in nitromethane.70 However, the analogous reaction of per-O-
acetyl-α-D-glucopyranosyl bromide71-74 gave per-O-acetyl-1,2-O-(1-cyanoethylidene)-α-D-
glucopyranose 36 in 53% yield, and only 11% of the preferred per-O-acetyl-β-D-glucopyranosyl 
cyanide 37. The preparation of per-O-acetyl-glycopyranosyl cyanides by Myers and Lee brought 
little improvement.75,76 
 Better overall yields of glycosyl cyanides could be obtained by exchange of the anomeric 
O-acyl group with the cyanide of trimethylsilyl cyanide (TMS-CN) in the presence of BF3-OEt2 
in nitromethane.77-80 Thus, per-O-acetyl-α/β-D-galactopyranoses could be directly converted into 
per-O-acetyl-β-D-galactopyranosyl cyanide. But, BF3-OEt2 is hazardous, unstable, and harsh, and 
significant decomposition and incompatibility with glycosidic bonds were observed. However, 
the elimination of the unstable glycosyl bromides as intermediates was a distinct advantage. We 



























Scheme 4. Synthesis of per-O-acetyl-β-D-glucopyranosyl cyanide 37.81-83 
 
 When per-O-acetyl-α- or β-D-glucopyranose was treated with excess TMS-CN and 
0.1 molar equiv of HgBr2 in nitromethane for 2 days in the absence of Hg(CN)2, the major 
product was the 1,2-cyanoethylidene derivative 36 in 59% yield, along with only 5% of the 
preferred cyanide 37, and about 28% of starting material (Scheme 4),81-83 similar to the results of 
Coxon and Fletcher with Hg(CN)2.71 When we increased the amount of HgBr2 to at least 0.5 
equiv, the cyanoethylidene intermediate rearranged into the desired per-O-acetyl-β-D-
glucopyranosyl cyanide 37 in 51% yield starting from per-O-acetyl-β-D-glucopyranose, or 65% 
yield from purified cyanoethylidene intermediate 36, within 1 day. Yields of rearrangement 
decreased to 5% when no TMS-CN was added along with the catalyst, and complete 
decomposition occurred on warming. The omission of Hg(CN)2 was crucial. This suggested that 
rearrangement required the assistance of a mercuric isocyanide complex in conjunction with the 
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Figure 5.  Molecular structure of the only isolated intermediate: per-O-acetyl-2-O-(1-exo-
ethylidene)-α-D-glucopyranose 36.84 
 
 Cano et. al.85 have already done extensive studies on the conformations of per-O-acetyl-1,2-
O-(1-cyanoethylidene)-α-D-glycopyranoses, which were obtained from the reactions of glycosyl 
bromides with potassium cyanide in tetrabutylammonium bromide/acetonitrile.86 X-Ray 
crystallographic84 and NMR analyses of the enantiomerically pure cyanoethylidene intermediate 
36 from our procedure showed it to exist in a twist-boat conformation of the six-membered cycle, 
with the cyanide exclusively in the exo-position (Figure 5). 
 With excess TMS-CN and 0.1 molar equivalents of HgBr2 in nitromethane, per-O-acetyl-
α(or β)-L-fucopyranose was converted into per-O-acetyl-β-L-fucopyranosyl cyanide 39 in 95% 
yield within 4 h. We observed neither the cyanoethylidene compound 38 as an intermediate86 nor 

























Scheme 5. Synthesis of per-O-acetyl-β-L-fucopyranosyl cyanide 39.81-83 
 
 The 1,2-O-(cyanoethylidene) glycopyranose side products were obtained by Myers and Lee 
in a larger yield from per-O-acetyl-D-gluco- and mannopyranose than from per-O-acetyl- 
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D-galactose.75,76 They tried to rearrange these syrupy byproducts into the corresponding α/β-
cyanides with boron trifluoride-etherate (BF3-OEt2) but improved the glycosyl cyanide yield 
only slightly. Kini et al. found it necessary to elevate the reaction temperature to 35 ºC to 
minimize formation of the 1,2-O-(cyanoethylidene) mannopyranoses when a mixture of per-O-
acetyl-α/β-mannopyranoses was converted with TMS-CN/BF3-OEt2 into α-D-mannopyranosyl 
cyanide.87 
 
4.2. Glycosyl cyanides from glycals and glycal dimers 
DeLas Heras et al. have shown that glycals, as well as glycosyl acetates, can be transformed with 
BF3-Me3SiCN in nitromethane into 2,3-unsaturated glycosyl cyanides, or glycosyl cyanides, 
respectively.79 The complex stereospecificity, if any, of such SN’-reactions has been discussed by 
March.88 More recently, alternative methods for the preparation of 2,3-unsaturated glycosyl 
cyanides from protected or unprotected glycals have been developed.89,90 We used a milder 
reagent for the introduction of a cyanide functionality, Hg(CN)2/HgBr2/Me3SiCN in THF/MeCN 
(2:3), to transform tri-O-acetyl-D-glucal 23 into 2,3-unsaturated di-O-acetyl-D-glucosyl cyanide 
40 (Scheme 6).62-64,91,92 
 We could use this reagent not only to convert O-glycosidic glycals into 2,3-eno-pyranosyl 
cyanides (Scheme 6) but also to obtain anomeric cyanides from glycal dimers and tetramers 
(Scheme 7) which are 2-C-2-deoxy-sugars.62-64,92 The reagent was compatible with 1,4- and 1,6-
O-glycosidic linkages, which are normally prone to cleavage in the presence of BF3.79 
 The reagent Hg(CN)2, HgBr2 and TMSCN, applied to compound 31, replaced the anomeric 
acetate group in ring A, to give the expected glycosyl cyanide 45 (Scheme 7).62-64 However, 
compound 33 (a dimer from tri-O-acetyl-L-fucal) gave unexpectedly the doubly unsaturated 
cyanide 47 (Scheme 7).62-64,92 Similarly, the galactal dimer 32 gave a doubly unsaturated cyanide 
46. Although the dimers 32 and 33 had only a stereochemical difference with 31 in the relative 
disposition of the 4-acetoxy group, the substitution of the anomeric acetoxy group was attended 
by elimination of AcOH, with deprotonation at C-2.62-64,92 A relief of steric strain may be a 
driving force for this elimination. Indeed, the molecular mechanics calculations (MM+) revealed 
a substantially higher steric strain (by 3-4 kcal/mol) in the most stable conformation of 33 when 
compared with 6A,6B-dideoxy analog of 31, which is a stereoisomer of 33. The remote C-4A 
acetoxy group, which functions as an internal base, may facilitate the deprotonation of an 
intermediate oxonium ion by intramolecularly removing and transporting the proton ultimately to 
external CN-, like a miniature crane. Such a “crane effect” does not work in 31, which has a 
different orientation of the C-4A acetoxy group.62-64,92 
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Scheme 6. Cyanation of per-O-acetyl-glucal and disaccharidic per-O-acetyl-glycals.62-64,91,92 
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45  (93%, α/β 1:2)
46  (81%, α/β 10:1)













































Scheme 7.  Cyanation products from glycal dimers.62-64,92 
 
4.3. Reduction of glycosyl cyanides 
One versatile approach to glycosyl cyanide modification, with which we have considerable 
experience, is catalytic reduction.81,82,93-96 Hydrogenation of per-O-acetyl-β-L-fucopyranosyl 
cyanide 39 with catalytic palladium-charcoal in the presence of acetic anhydride (Ac2O) gave the 
isolated O-N-acetyl migrated products 49 and 50 in 32% and 23% yields, respectively  
(Scheme 8).81,82,94-96  The yield for the N-linked aminodisaccharide 50 decreased to 9% without 
the presence of Ac2O. Since the presence of Ac2O did not prevent migration, it appeared that  
O-N-acetyl migration from a 2-O-acetoxyl group was much faster than acetylation of the amines. 
The 2-hydroxyl amino-C-monosaccharide 49 and C-disaccharide 50 can be acetylated with Ac2O 
in the presence of catalytic 1,4-(dimethylamino)pyridine (DMAP) to the corresponding fully 
protected 51 and 52 before or after isolation.81,82,94-96 
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 In the presence of the lipophilic Boc2O, the hydrogenation of cyanide 39 on Pd/C gave only 
53 and an N-linked disaccharide 54 in 61% and 38% yields, respectively, without O-N-acetyl 
migrations (Scheme 8).81,82,94-96 Again, the yield of disaccharide 54 was increased in presence of 
the anhydride. 
 Cyanides are reduced with H2/Pd in two stages.97 The first stage is formation of aldimine, 
and the second is reduction to the corresponding amine. In the production of 49 and 50, O-N-
acetyl migration could occur at the aldimine or amine stage. The migration at the stage of amine 
made it unavailable for further reaction. That no acetyl migratory product was observed in the 
presence of Boc2O suggests fast reaction of aldimines and amines with Boc2O at the lipophilic 
charcoal catalyst surface. In contrast, hydrophilic Ac2O, present in the bulk solution, permits 
acetyl migrations at the surface. The more electrophilic acylated aldimines tend to favor 
dimerization, which indeed occurred more readily in the presence of Ac2O and Boc2O.81,82,94,95 
This point was not appreciated by Lentz et al. in their later work with Boc2O,98 probably because 
they did not compare hydrogenation in the presence of Ac2O, as we did. 
 From the Boc-protected aminomethyl-C-fucopyranoside synthons, a great variety of 
biologically interesting glycoconjugates are accessible. Transformation of the 1° amino 
functionality into an isocyanate allows coupling with the former 1° amine or the 2° amine dimer.  
Other nucleophiles would give glycoconjugates with minimal scaffolding such as unsymmetrical 
ureas. This could be accomplished in many ways, but most commonly by phosgenation,99 which 
is economical and practical, since the advent of crystalline “triphosgene”. We removed the 
Boc-protective group from the aminomethyl-C-monosaccharide 53 with TosOH-H2O in CH2Cl2, 
and the resultant salt, in solution, was directly converted with 1/6 equivalents of triphosgene in a 
CH2Cl2-saturated sodium bicarbonate two-phase system (Scheme 8), via the in situ amino- and 
isocyanato-monosaccharide intermediates, into the novel di-fucopyranosyl methyl-substituted 
urea 55 in 63% yield, along with 49 (12%) through O-N-acetyl migration.81,82,94-96 
 When the same deprotection and two-phase phosgenation was applied to the N-linked 
disaccharide 54, a novel tetra-fucopyranosyl methyl-substituted urea 57 (28%) was obtained 
along with the O-N-acetyl migratory side-product 50 (48%) and the stable crystalline carbamoyl 
chloride 56 (15%; Scheme 8) - a potentially useful reactant for preparation of more complex C-
glycosidic conjugates. The yield for the tetra-substituted urea derivative was surprisingly high 
for a bimolecular reaction of two sterically hindered intermediates, which had to compete with 
the major intramolecular pathway of acetyl migration, after Boc removal. Formation of acetyl 
migratory side products 49 and 50 was increased if a weaker acid such as trifluoroacetic acid was 
employed to remove the Boc-protective group, or if Hűnig’s base was used in a single non-polar 
organic solvent instead of a two-phase system with aqueous bicarbonate. With an excess (1/3 
equivalents) of triphosgene, acetyl migratory product was minimized, and formation of the tetra-
substituted urea also ceased, but the yield of the interesting carbamoyl chloride 56 increased to 
67%.  It was successfully isolated by column chromatography on normal SiO2, by elution with 
isopropyl ether.81,82,94-96 
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NHR' 49 R = H, R' = Ac
51 R = R' = Ac













50 R = H, R' = Ac
52 R = R' = Ac




















































Scheme 8. Reduction of glycosyl cyanides, and further transformations of the products.81,82,94-96 
 
 Scheme 8 summarizes the synthetic possibilities for the two readily obtainable 
Boc-aminomethyl saccharides 53 and 54. The utility of compounds 53, 54, and 56 is readily 
appreciated, for attaching stable β-L-fucopyranosyl residues via amide, urethane, or urea bonds to 
carboxyl, hydroxyl, or amino groups of proteins or other biological scaffolds, to produce e.g. 
“neoglycoproteins.” This methodology should be extendable to other sugars. 
 We have shown that O-acetyl protective groups are removable under very mild conditions, 
with NEt3/MeOH/H2O.100 The base and the byproduct AcOH are smoothly removed by 
azeotropic water vapor distillation in vacuo, or presumably also by freeze drying, without 
damage to delicate biochemical substrates. 
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5. Henry Condensation 
 
One of the most common methods for the chain extension of carbohydrates is the Henry 
condensation of pentoses and hexoses with nitromethane in the presence of a strong base. In 
1946 Sowden and Fisher condensed 4,6-O-benzylidene-D-glucopyranose 59 (Scheme 9) with 
nitromethane in the presence of methoxide to give D-heptitol 60 and nitromethyl 
β-D-glucopyranoside 63 in 21% and 5% yield, respectively.101 Later, Petrus et. al. improved the 
total yields of unprotected nitromethyl D-hexopyranosides, but their approach is lengthy and 





) in these procedures in protic solvents lead to open-chain products (i.e. 
60, Scheme 9).101 Their hot dehydration gives cyclic forms, reverting only very slowly to acyclic 
at low temperatures.103 Presumably, acyclic forms, having more hydroxy groups, are stabilized 
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Scheme 9. Henry condensation of protected and unprotected β-D-glucopyranose.82,104-107 
 
 We had synthesized82,104-107 directly the cyclic compounds in aprotic solvents with a highly 
active bifunctional108 catalyst 2-hydroxypyridine109 and DBU/molecular sieves104 with an 
improved  yield of 77%.105 We avoided protic solvents because of the strong basicity of DBU, 
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which would provide just another way of creating RO- in ROH. The cyclic product 63 was 
produced in a single step along with two minor byproducts 60 and 64.104 
 We reinvestigated later82,106,107 our original condensation104,105 of nitromethane with  
4,6-O-benzylidene-D-glucopyranose 59 to nitromethyl 4,6-O-benzylidene β-D-glucopyranoside 
63 and discovered that 2-HP was unnecessary. A time study, with careful TLC analysis and flash 
chromatography of the reaction mixture with DBU and molecular sieves revealed sequential 
products, which are conveniently explained as outlined in the mechanistically simplified Scheme 
9. 
 The condensation progressed similarly in THF and dioxane, with 4,6-O-benzylidene- 
D-glucopyranose via 5,7-O-benzylidene-1-deoxy-1-nitro-D-glycero-D-gulo-heptitol 60, which 
subsequently changed into nitromethyl β-D-glucopyranoside 63. The former was observed 
accumulating before being further converted during at least 50 hours at room temperature to the 
cyclic product 63, along with some 5,7-O-benzylidene-1,2-dideoxy-1-nitro-2-nitromethyl- 
D-gluco-heptitol 64, in yields similar to those already reported.104,105 In THF or dioxane, 
accumulation of the final acyclic product 64 was dependent on temperature, time, and solvent: 
less decomposition was observed in dioxane. In these condensations, we could not determine if 
the presence of 2-HP had any effect at all, at any stage of the reaction. In any case, the first 
heptitol 60 and the desired 63 were kinetically controlled intermediates, which, given enough 
time, were transformed into the “thermodynamic” product 64, by a still slower overall rate. 
 When similar conditions were employed for unprotected D-glucose 58, there was no reaction 
for prolonged periods of time. Heating only resulted in almost complete decomposition. This was 
expected since unprotected sugars are typically not very soluble in THF or dioxane. But in 
acetonitrile, pyridine or a mixture of these at 50 °C, the condensations were fairly clean.82,106,107 
The condensation progressed to completion within one day, and only nitromethyl β-D-
glucopyranoside 62 (Scheme 9) was detected and isolated when 5:1 acetonitrile/pyridine (38% 
yield) or pyridine was used as the solvent (57% yield). For completion and maximal yield, a 
stoichiometric amount of DBU was needed.  
 Condensations with L-fucose 65 were monitored by TLC and flash chromatography, and 
gave sequential products as outlined in Scheme 10.82,106,107 Within 12 h in THF more than half of 
the starting L-fucose was converted into corresponding 1,6-dideoxy-1-nitro-L-glycero-D-manno-
heptitol 66. By the end of day 3, most of L-fucose had been transformed into the acyclic heptitol 
66, and the subsequent conversion into cyclic nitromethyl β-L-fucopyranoside 67 was followed 
for another 5 days, during which time a significant portion of the desired cyclic product 67 had 
also been slowly converted into 1,1,6-trideoxy-1-nitro-2-nitromethyl-L-galacto-heptitol 68. Thus, 
the maximal yield for product 67 required minimizing decomposition and the yields of 66 and 
68.  In dioxane, only 67 was isolated as the product (62%). On the contrary, 50% 68 vs. 5% 67 
were obtained in DMF. The results suggest that solubility might be the most important factor to 
affect Henry condensations of unprotected sugars. 
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Scheme 10. Henry condensation of unprotected L-fucose 65.82,106,107 
 
 A possible further transformation of the synthesized nitro-compounds is illustrated by the 
reduction of nitromethyl β-D-glucopyranoside 63 with a specially prepared elemental iron in 




















6. Condensation with Malononitrile 
 
As described above, Henry condensation with nitromethane of partially protected and non-
protected pyranoses with a free anomeric hemiacetal function in presence of DBU and molecular 
sieves produces C-glycosides, which molecules incorporated one or two molecules of 
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nitromethane (an example of L-fucose reaction is shown on Scheme 10). The ratio of products 
substantially depended on conditions of the reaction.82,104-107  
 Inspired by this result, we explored a possibility of a similar synthesis of  
C-glycosides using malononitrile (MN) instead of nitromethane as an active methylene component 
(Scheme 12).110,111 Malononitrile is a versatile compound of exceptional reactivity.112,113 It is 
often used as a reactant for synthesis of heterocycles since the methylene group and either one or 
both cyano groups can take part in condensation reactions to give a variety of addition products 
and heterocyclic compounds.114-116 MN has not been used for preparation of C-glycosides, 



























Scheme 12. Expected products from the reaction of L-fucose with malononitrile. 
 
 L-Fucose 65 was selected as a starting carbohydrate. We expected products similar to those 
obtained in reaction with nitromethane (Scheme 10). However, the reaction was much faster (1 h 
instead of several days), and neither mono-adduct 70 nor bis-adduct 71 (Scheme 12), which are 
analogs of 67 and 68 (Scheme 10), was obtained. Instead, two cyclic compounds 73 (oil) and 74 
(white crystals) in a ratio ~5:1 (by NMR) were isolated by a column chromatography of the 
reaction mixture (Scheme 13).110,111 
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Scheme 13. Condensation of L-fucose and malononitrile in presence of DBU. 
 
 The bicyclic structure 74 was proven by X-ray crystallography (Figure 6).110,118 
Interestingly, the solution conformation (in CD3OD) of the side chain in 74 estimated from the 
vicinal spin-spin couplings in 1H NMR correlated well with the crystal structure data.111 To the 
best of our knowledge, no compounds have been described so far with this combination of five- 
and six-membered oxygen-containing heterocycles. 
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Figure 6. Molecular structure of the bicyclic product 74.110,118 
 
 The results of the synthesis may be rationalized as a sequence of (a) Knoevenagel 
condensation producing intermediate 72, then (b) Michael addition of another MN resulting in 
formation of bis-adduct 71, and then (c) a base-induced double cyclization. The latter can occur 
via either the dihydrofuran derivative 73, or the dihydropyran derivative 73a. However, we 
isolated only one monocyclic compound, which structure could not be assigned based on NMR 
data. In an attempt to prepare a crystalline derivative appropriate for X-ray analysis, we 
acetylated product 73 (Scheme 14) and obtained the furan derivative 75, which NMR parameters 
perfectly matched the parameters of similar furan derivatives described in literature.119 This 
result suggests the structure 73 as the intermediate monocyclic compound isolated in the reaction 























Scheme 14.  Acetylation of monocylic compound 73. 
 
 
7. Total Syntheses of Aminomethyl-C-dideoxyglycopyranosides and their 
Quinamides 
 
The great majority of methods developed for the synthesis of C-glycosides18-20 start from natural 
sugars, mostly D-glucose, D-mannose and D-galactose, which are commercially available in 
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multigram quantities.120 Other D-monosaccharides and all L-monosaccharides are very expensive 
and available only on a milligram scale.120 Moreover, D-gulose, D-altrose and D-idose exist in 
appreciable proportions as their 1,6-anhydrides with essentially different chemical behaviour.121 
We developed an approach to the total syntheses of partially functionalized β-C-
glycopyranosides,49,93,122-128 related to 2,4- and 4,6-dideoxyhexoses, found as cardiac 
glycosides.129,130 These C-glycosides are tetrahydropyrans obtained from homoallylic alcohols and 
acetals by a Lewis acid promoted cyclization, followed by dehydrohalogenation and subsequent 
double bond functionalization.49,93,122-128 A subsequent use of these building blocks for the 
syntheses of di- and oligosaccharide mimics is illustrated by their quinoylation. Quinic acid is an 
important structural component in a number of naturally occurring biologically active compounds 
which exhibit HIV-integrase inhibition,131-133 as well as hypocholesterolemic,134 
hepatoprotective135 and antioxidative136-138 activities. A combination of racemic aminomethyl C-
glycosides with chiral quinic acid may directly yield biologically active chiral compounds. 
 Acid catalyzed reactions between homoallylic alcohols and aldehydes or acetals have been 
used before for the preparation of 2,6-disubstituted di- and tetrahydropyran derivatives (see Ref. 92 
and references therein). We chose an expandable two-component scheme of cyclization with a 
possibility of various functional groups in readily available starting compounds. Use of 
phthalimido derivatives allowed for syntheses of (protected) aminomethyl C-glycopyranosides 
(Scheme 15). 
 Cyclizations of this type furnish exclusively cis-2,6-disubstituted tetrahydropyrans49,93,122-128 
corresponding to the β-configuration of the projected C-glycopyranosides. Most C-glycoside 
syntheses provide α-products.19,20 The new stereocenter C(6) is entirely determined by the 
configuration of the existing stereocenter in the homoallylic alcohol. Chiral homoallylic alcohols 
would give enantiomerically pure tetrahydropyrans, and finally C-glycosides. We obtained racemic 
aminomethyl C-glycosides, subsequently acylated with the chiral lactone of quinic acid 11 
(Scheme 15), and separated as derivatives of diastereomeric quinamides (Scheme 16). 
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Scheme 15. Synthesis of aminomethyl-C-glycosides and their quinamides (76-83: stereoisomeric 
mixtures; 84-95: racemic mixtures; Phth = phthaloyl)49,93,122-128: (a) SnCl4, CH2Cl2, -55oC, 82%; 
(b) DBU, LiCl, Py, reflux, 79%; (c) Urea-H2O2, TFAA, 93%; (d) TFA, H2O/THF, 60oC, 74%; (e) 
OsO4, NMO, 64%; (f) 1) Me2NH, MeOH, H2O, 2) H2SO4, H2O, 3) NH4OH, 80-86% (88-91: R = H); 
(g) Ac2O, DMAP, Py, 51-85% (92-95: R = Ac); (h) 11, DMA, 70oC, 58-77%; (i) acetone, p-TsOH, 
reflux, 86%; (j) BnNH2, DMA, 550C, 72%. 
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Scheme 16. Separation of diastereomeric mixtures of quinamides as isopropylidene-tetra-O-
acetyl or diisopropylidene derivatives: (a) Ac2O, DMAP, Py; (b) 2-methoxypropene, p-TsOH, 
DMF.49,128 
 
 Specifically for the synthesis of various homoallylic alcohols (Scheme 15), we developed 
new methods: transallylation139 and allylation in aqueous phase140,141 of commercially available 
and relatively stable aldehyde acetals. Acid promoted cyclization of pent-4-en-2-ol with the 
phthalimido derivative of 2,2-diethoxyethylamine at –55oC in CH2Cl2 solution with SnCl4 
(Scheme 15) gave chlorotetrahydropyrans 76 and 77 (5:1, separable by column 
chromatography). The alkenes 78, 79 were obtained as a 2:1 mixture (by NMR) by heating of the 
mixture 76, 77 with DBU in pyridine in presence of LiCl, which facilitated in situ isomerization 
of equatorial into axial halogen, suitable for trans-elimination. Epoxidation of the alkene mixture 
with the urea-H2O2 complex in presence of (CF3CO)2O (TFAA)142 produced an epoxide mixture 
80-83 (93%), which was difficult to separate. However, the well known tendency of epoxides to 
open trans-diaxially,143 allowed for direct synthesis of a two-component trans-diol mixture 84, 
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85, separated by column chromatography (51% and 23% respectively). After cis-dihydroxylation 
(OsO4 /NMO) of the mixture 78, 79, only compounds 86 and 87 were isolated (45% and 19% 
respectively). 
 Thus, we obtained a series of four racemic phthalimido-protected aminomethyl  
C-dideoxyglycopyranosides 84-87, which produced with aq. Me2NH144 the dimethylammonium 
salts of phthalamic acids. They were hydrolyzed after evaporation of excess Me2NH by heating 
with aq. H2SO4 (70oC), followed by extraction of phthalic acid with CH2Cl2 and Et2O. 
Neutralization by NH3 aq. and subsequent evaporation followed by column chromatography 
gave compounds 88-91 (80-86%), characterized and analyzed as their N-acetyl- and/or N,O-
triacetyl derivatives, and used as building blocks for pseudodisaccharides. Acylation of 
benzylamine with the isopropylidenated γ-lactone of quinic acid 11145,146 provided us with H1 
NMR chemical shifts and coupling constants for the quinoyl part of compound 96. Similarly we 
converted racemic C-glycosides 88-91 into their quinamides 97-103 (i. e. into diastereomeric C-
pseudodisaccharides; Scheme 15). 
 Generally, separation of diastereomeric pairs 97-103 could only be achieved via their 
derivatives (Scheme 16). Thus, the trans-dihydroxy aminomethyl C-glycosides 97, 98 were 
separated as their O-acetyl derivatives by flash chromatography to produce 104 (or 105)(7%), 
105 (or 104) (28%), and 104+105 (32%). Quinamides 102, 103 were isopropylidenated, and the 
mixture 106, 107 was enriched with one of the stereoisomers (9:1) by column chromatography. 
 
 
8. C-Glycosides via Cycloadditions 
 
The aqueous hetero-Diels-Alder reaction has been investigated by A. Lubineau et. al.,147-151 for 
the synthesis of dihydropyran cyclo-adducts. We wanted to explore their use, through 
dihydroxylation of the double bond for syntheses of C-glycosides,152,153 as mimetics of naturally 
occuring 2,6-dideoxy sugars.154 Technical 1,3-pentadiene (piperylene) and aq. glyoxylic acid are 
inexpensive commercial products, which were used as starting materials. The reaction was 
regioselective in the intended way, most likely because of the electron donating property of the 
methyl group of pentadiene. The cis- and trans- acids were obtained in comparable amounts 
(Scheme 17).152,153 Their direct separation by chromatography was unsuccessful. However, 
methylation of the crude acid product 108, 109 rendered the mixture 110, 111 separable on TLC, 
and by column chromatography. In this way we obtained suitable starting materials for the 
following dihydroxylations. 
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Scheme 17.  Synthesis of 2,6-anhydro-2,4,5,6-tetrahydroxy-D,L-heptanoic acid esters:152,153  
(a) 100oC, 56%; (b) CH2N2; (c) OsO4, NMO; (d) Urea-H2O2, TFAA; (e) TFA/ H2O. 
 
 The cis-isomer 111 gave only one major racemic product of cis-dihydroxylation (112). It is 
not clear why the molecule 111 does not allow OsO4 approach from both sides. Similarly, the 
epoxidation of 111 gave a crude epoxide 113 (Scheme 17) in 84% yield, the NMR and TLC of 
which showed no evidence of the epoxide with opposite configuration. Its purification by column 
chromatography proved to be difficult, due to its instability. As expected, acid hydrolysis 
(113→114) gave a single major product, which could be isolated pure after esterification to 115 
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(81% overall; Scheme 17). It is advantageous, that any “opposite epoxide” in the crude mixture 
also would give preferentially the same diaxial hydrolysis product 114.143 
 cis-Dihydroxylation of trans-isomer 110 gave a mixture of stereoisomeric 116 and 117 (ratio 
3:1 by NMR; overall yield 73%). Compound 116 was crystallized from the mixture (57%). 
Compound 117 was not successfully isolated from the mother liquor, but its 1H-NMR parameters 
were determined from the mixture. 
 The epoxidation of trans-ester 110 gave two epoxides 118 and 119 as detected by TLC. 
Their mixture was subjected to hydrolysis and methylation to give a mixture of trans-dihydroxy 
esters 120 and 121, which was separated by column chromatography (yields 38% and 43% 
respectively).  
 We also tried to separate the carboxylic acids 108 and 109 by the reaction of NBS with their 
mixture. Only the trans-isomer 108 reacted with NBS to form a bromolactone, and the lactone 
122 was easily separated from the reaction mixture, but the yield was too low (15-25%).  The 
nature of the side reaction of the trans-isomer with NBS could not be determined. The 
bromolactone 122 was cleaved by NaOMe to give the single epoxide 118 which was hydrolyzed 
to give a single carboxylic acid 120, providing another structure proof for it (Scheme 17). 
 Thus, the hetero-Diels-Alder reaction between inexpensive 50% aq. glyoxylic acid and 
technical grade piperylene provided a starting point for synthesis of a series of 2,6-anhydro-
2,4,5,6-tetrahydroxy-D,L-heptanoic acid esters,152,153 which are C-glycosidic analogs of 
2,6-dideoxypyranoses, prominent in cardiac glycosides.154 
 When racemate 112 and 4,6-O-benzylidene-β-D-glucopyranosyl methylamine 99104 were 
refluxed in methanol in presence of a catalytic amount of NaOMe, the reaction was completed in 



































Scheme 18. Amide coupling of 112 with 123. 
 
 Such conjugates with natural carbohydrate derivatives offer potential for chiral resolution. 
Glycobiological applications for these compounds appear very possible. 
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9. Hydroxy-derivatives of 1,2-cyclohexanedicarboxylic Acids 
 
The structure of inhibitors usually resembles a substrate, a transition state, or a product of 
enzyme-catalyzed reaction.18-23 From this point of view, various polyhydroxylated five- and six-
membered cyclic compounds may be considered as monosaccharide structural analogs, and thus 
potential inhibitors of glycosidases. In a search for simple, readily accessible, but efficient 
glycosidase inhibitors, we designed, prepared, and assayed a series of cyclohexanecarboxylic 
acids and esters of types 125-131 with different substitution pattern, configuration, and length of 




































R = H, Alk
 
 
Figure 7. Potential glycosidase inhibitors: cyclohexanecarboxylic acids and their esters.111,155-158 
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R = H (a), CH3 (b), Et (c), n-Pr (d), n-Bu (e), n-C5H11 (f), n-C6H13 (g), n-C7H15 (h), 

























Scheme 19. Preparation of 4-HO-5-RO-1,2-cyclohexanedicarboxylic acids 129-131.111,155-158 
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 The proposed structures contained a six-membered cycle and several hydrophilic groups, 
which is typical for many carbohydrate mimetics (see above). Alkyl groups were introduced to 
enhance the inhibiton. Such effect of lipophilic groups was observed previously18-23 for 
derivatives of 1-deoxynojirimycin and other iminosugars, alkyl glycosides, and some other 
glycosidase inhibitors. The preliminary tests against fungal glycosidases revealed only a weak to 
moderate inhibition of β-D-glucosidase by compounds 125 (R = H) and 127+128 (R = CH3, n-
C6H13),  and a weak inhibition of α-L-fucosidase by compounds 125+126, and 127+128 (R = 
CH3, n-C6H13).111,155,156 However, very promising results were obtained for 
cyclohexanedicarboxylic acids of types 129-131.111,155-158 The synthesis of compounds 129-131 
is presented in Scheme 19. It employed very simple starting compounds and reagents, and rather 
standard synthetic procedures. 
 These diacids were assayed for inhibitory activity against several glycosidases in multi-
enzyme complexes isolated from fungi Penicillium canescens and Aspergillus oryzae.111,155-158 
The inhibition was found to be specific with regard to the configuration of inhibitor, the type of 
enzyme, and even the particular source of enzyme. Most noticeably, these compounds inhibited 
α- and β-D-glucosidases. The isomers 130 and 131 appeared to be more selective inhibitors. It is 
worth mentioning that the compound 129e produced the same inhibition effect upon  
β-D-glucosidase from A. oryzae, as a ~10-fold higher concentration of methyldeoxynojirimycin. 
 The results of our studies proved that simple and readily available racemic derivatives of 
1,2-cyclohexanedicarboxylic acid can be potent inhibitors for α- and β-D-glucosidases The 
presence of at least two carboxylic groups and one hydroxy group was found to be essential for 
efficient inhibition. Its magnitude depended on configuration of substituents and increased for β-
glucosidase with lengthening of the inhibitor’s alkoxy group. Further studies towards the 
enhancement of inhibitory activity may be focused on separation of enantiomers, on variation of 
the substituent configuration, of the length and structure of the lipophilic groups, and of the 
nature of heteroatoms. These compounds may be considered as promising precursors for 
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